Health

111, Inc. to Attend the Credit Suisse 2019 Asia Healthcare Corporate Days in Hong Kong, June 5-6, 2019

SHANGHAI, May 31, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will participate in the Credit Suisse 2019 Asia Healthcare Corporate Days inHong Kong, June 5-6, 2019. Mr. Luke Ch...

2019-05-31 19:15 6780

111, Inc. to Attend the T.H. Capital China TechNet + Investment Conference in Beijing, June 3-4, 2019

SHANGHAI, May 31, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will present at the T.H. Capital China TechNet + Investment Conference inBeijing, June 3-4, 2019. Dr. Gang Yu, Co-...

2019-05-31 17:56 6509

New Zealand's Leading Tobacco Control Expert Questions Budget Tobacco Tax Increase

As World No Tobacco Day is marked around the world, Dr. Marewa Glover calls for a fairer and more science-based approach tosmoking cessation and harm reduction  AUCKLAND, New Zealand, May 31, 2019 /PRNewswire/ -- One of New Zealand's most renowned tobacco control researchers is questioning th...

2019-05-31 05:10 4915

CartiHeal's Agili-C™ Implant Enhances In-vitro Osteogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells

KFAR SABA, Israel, May 30, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of osteochondral and chondral defects, announced today the publication of anin-vitro study demonstrating that the Agili-C™ implant enhances osteogenic differentiation of human...

2019-05-30 20:00 1988

Conagen announces formation of Scientific Advisory Board

Board includes five world-leading scientists in the fields of Synthetic Biology and Applied Molecular Biology  BEDFORD, Massachusetts, May 30, 2019 /PRNewswire/ -- Conagen Inc., a vertically integrated synthetic biology and fermentation company, announced today the formation of a new scientific ...

2019-05-30 20:00 2150

CytoDyn and Samsung BioLogics Formalize Manufacturing Partnership

INCHEON, South Korea, May 30, 2019 /PRNewswire/ -- CytoDyn Inc., a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications and Samsung BioLogics met at the Samsung BioLogics Songdo headquarters for an official ...

2019-05-30 19:00 2529

Chinese Nutrition Society Launches Healthy China Nutrition Union to Empower the National Health

BEIJING, May 30, 2019 /PRNewswire/ -- Introduction May 29, 2019. With the objective to implement the Healthy China 2030 Planning Outline, the Launch Conference of the Healthy China Nutrition Union, led by Chinese Nutrition Society and supported by Mengniu Dairy, was officially held in Beijing. Rep...

2019-05-30 14:08 2756

Thermo Fisher Scientific and Scinogy Partner to Accelerate Cell and Gene Therapy Commercialization

New collaboration will enable scalable, cost-effective manufacturing processes CARLSBAD, California, May 30, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for...

2019-05-30 04:01 3212

Singlera Genomics ColonES test selected as finalist for AACC Disruptive Technology Award

SAN DIEGO, May 29, 2019 /PRNewswire/ -- Singlera Genomics, which focuses on non-invasive early cancer detection through circulating tumor DNA methylation haplotyping analysis, was selected as one of three finalists for the second annual AACC Disruptive Technology Award.  AACC Disruptive Technolo...

2019-05-29 21:00 1240

CE Certification for AI-based Medical Solutions of JLK Inspection: AI-based Brain Image Analysis (JBS-01K) and AI-based Prostate Image Analysis (JPC-01K) Solutions

SEOUL, South Korea, May 29, 2019 /PRNewswire/ -- JLK Inspection , a company specializing in world-class AI-based medical imaging solutions and a company of theBorn2Global Centre , has developed JPC-01K

2019-05-29 20:30 1482

Sihuan Pharm Obtained Phase I to III Clinical Trial Approval for the Third Generation of EGFR Inhibitor XZP-5809

HONG KONG, May 29, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), the largest cardio-cerebral vascular ("CCV") drug manufacturer inChina's prescription drug market, announced the third generation of EGFR inhibitor XZP-5809, a Category 1 innovative drug developed by t...

2019-05-29 18:00 4932

Samsung BioLogics to Showcase End-to-End CDMO Capabilities at BIO International 2019

INCHEON, South Korea, May 28, 2019 /PRNewswire/ -- For the ninth consecutive year since the company's foundation in 2011, Samsung BioLogics will be showcasing its full end-to-end CDMO capabilities at the BIO International 2019 convention inPhiladelphia, PA, June 3rd to 6th.

2019-05-29 12:27 1855

Alphamab Oncology Announces Completion of US$60 Million Series B Financing

SUZHOU, China, May 28, 2019 /PRNewswire/ -- Alphamab Oncology, a leading biopharmaceutical company dedicated to global development of innovative biologics for cancer therapy, announced today that it has completed aUS$60 million Series B financing led by Hudson Bay Capital Management LP and parti...

2019-05-28 19:02 2632

World First Test Breakthrough to Boost IVF Success Rates

MELBOURNE, Australia, May 28, 2019 /PRNewswire/ -- A new revolutionary non-invasive embryo screening testwill reduce miscarriages and the time it takes to achieve a healthy live birth for the one-in-six Australian couples affected by infertility. In a world-first scientific breakthrough, Austral...

2019-05-28 13:40 1622

Nanjing YiGenCloud Institute aims to speed up the process of China's precision medicine with "intelligence"

NANJING, China, May 27, 2019 /PRNewswire/ -- Xinjun He, Ph.D., the executive director of Nanjing YiGenCloud Institute, a leading medical big data AI company inChina, described the blueprint of their China's precision medicine at the Nature conference: Genome Variation in Precision Medicine 2019he...

2019-05-27 20:25 2293

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

NESS ZIONA, Israel, May 27, 2019 /PRNewswire/ -- Ori Yehudai: "I took a company worth$3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants...

2019-05-27 20:05 2555

Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for "Non-PVC Solid-Liquid Double Chamber Bag for Ceftazidime/Sodium Chloride Injection"

HONG KONG, May 27, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Group"), the largest cardio-cerebral vascular ("CCV") drug manufacturer in China's prescription drug market, announced the "non-PVC solid-liquid double chamber bag for ...

2019-05-27 17:08 5064

111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System

SHANGHAI, May 24, 2019 /PRNewswire/ -- Following 111, Inc.'s (NASDAQ: YI) ("111" or the "Company") strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. OnMay 24, 111 and MSH, a world leader in the design and management of international healthcare solu...

2019-05-24 22:45 8416

CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery

SHANGHAI, May 24, 2019 /PRNewswire/ -- With fast advances in the medical industry, onMay 11, 2019, the third OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was successfully held inGuangzhou. The summit was sponsored by the Chinese Thoracic Oncology Group (CTONG) and the ...

2019-05-24 19:00 4473

B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System

TOKYO, May 24, 2019 /PRNewswire/ -- B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system (LINAC). More than 180,000 patients have been treated in proto...

2019-05-24 14:00 2525